$GMED 3 SEC Filings

Filed On	Filing
27 Aug 2025	Form 3: Kline Kyle, Senior Vice President, CFO
06 Sep 2023	Form 3: Wolterman Dan, Director No securities owned
06 Sep 2023	Form 3: Norwalk Leslie V, Director No securities owned
06 Sep 2023	Form 3: DeFord John A, Director No securities owned
17 Dec 2019	Form 3: Douglas Robert Andrew, Director Holds 0 shares of No securities are beneficially owned
26 Aug 2019	Form 3: Pfeil Keith W, SVP, Chief Financial Officer Holds 0 shares of No securities are beneficially owned
03 May 2019	Form 3: Zarrilli Stephen T, Director Holds 0 shares of No securities are beneficially owned
06 Mar 2019	Form 3: Huller Kelly, SVP, General Counsel Holds 15,384 shares of Class A Common Stock
18 Jan 2018	Form 3: Schwartz Eric, Senior VP and General Counsel
01 Sep 2015	Form 3: Tobin James R, Director Holds 0 shares of No securities beneficially owned
14 May 2015	Form 3: Scavilla Daniel T, Senior VP and CFO
05 Mar 2015	Form 3: Williams Anthony L, Senior VP of Bus. Devel. & GC
11 Jun 2013	Form 3: Payne Steven, Chief Accounting Officer Holds 23,076 shares of Class A Common Stock
02 Aug 2012	Form 3: Goldman Sachs Private Equity Partners 2004 Offshore HOLDINGS, L.p., 10% owner and 9 others Holds 553,845 shares of Class A Common Stock
02 Aug 2012	Form 3: Goldman Sachs Group Inc, 10% owner and 8 others Holds 553,845 shares of Class A Common Stock
02 Aug 2012	Form 3: Clarus Lifesciences I, L.p., 10% owner and 8 others Holds 604,265 shares of Class A Common Stock
02 Aug 2012	Form 3: Wheeler Kurt, Director Holds 604,265 shares of Class A Common Stock
02 Aug 2012	Form 3: Rhoads Ann D, Director
02 Aug 2012	Form 3: Paul David C, Director
02 Aug 2012	Form 3: Murphy A Brett, Executive VP, US Sales Holds 76,923 shares of Class A Common Stock

Comments